4'-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,1'-biphenyl]-4-ol, 98%, 1g

2-(2-methoxy-4-methylphenoxy)propanoic acid, 95.0%, 500mg

2,2,6,6-Tetramethylpiperidin-4-one oxime, 98%, 10g

2,4-Dinitrodiphenylamine>98.0%(GC)25g

((2R,7aS)-2-Fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl)methanol, 95%, 100g

H-Phe-NH2, 95%, 10g

N-(3-aminophenyl)-2-methoxyacetamide hydrochloride hydrate, 95.0%, 5g

3-FLUORO-1-METHYL-1H-PYRAZOL-4-AMINE, 95%, 1g

(S)-4-(1-(tert-butoxycarbonyl)ethyl)benzoic acid, 98%, 100mg

3-[(E)-2-pyridin-2-ylvinyl]aniline, 95.0%, 1g

trans N,N'- Dimethylcyclohexane-1,2-diamine, 99.0%, 1g

2,5-Dichloro-4-(trifluoromethyl)pyrimidine, 95.0%, 250mg

(R)-2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)(METHYL)AMINO)-4-(TERT-BUTOXY)-4-OXOBUTANOIC ACID, 95%, 5g